The joint Nuclear Medicine department of the University hospital of Nantes and the ICO has all the expertise required to carry out clinical trials in the fields of imaging, dosimetry and molecular radiotherapy in oncology, cardiology and neurology: radiolabelling, automated synthesis machines, SPECT-CT, PET-CT, shielded chambers.
PET – view taken at the ICO
The In-house Hospital Radioiopharmacy (APUI) of the University Hospital of Nantes, located in Arronax, is equipped with shielded cells, quality control instruments and automatic systems for the purification, synthesis and distribution of radioisotopes and radiopharmaceuticals for clinical trials in local and national clinical centres.
Ongoing clinical trials as of June 30, 2020 :
- Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs (sponsor : Ipsen)
- 64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum) (sponsor : Western Cancer Institute – ICO)
- Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1 (sponsor : Ipsen)
APUI production chambers in Arronax